BMC Medical Ethics 22 (1):1-15 (2021)

Background Breakthroughs in animal studies make the topic of human application of ectogenesis for medical and non-medical purposes more relevant than ever before. While current data do not yet demonstrate a reasonable expectation of clinical benefit soon, several groups are investigating the feasibility of artificial uteri for extracorporeal human gestation. Main text This paper offers the first comprehensive and up to date discussion of the most important pros and cons of human ectogenesis in light of clinical application, along with an examination of crucial ethical issues that continued research into, and the clinical translation of, ectogenesis gives rise to. The expected benefits include advancing prenatal medicine, improving neonatal intensive care, and providing a novel pathway towards biological parenthood. This comes with important future challenges. Prior to human application, important questions have to be considered concerning translational research, experimental use of human fetuses and appropriate safety testing. Key questions are identified regarding risks to ectogenesis’ subjects, and the physical impact on the pregnant person when transfer from the uterus to the artificial womb is required. Critical issues concerning proportionality have to be considered, also in terms of equity of access, relative to the envisaged application of ectogenesis. The advent of ectogenesis also comes with crucial issues surrounding abortion, extended fetal viability and moral status of the fetus. Conclusions The development of human ectogenesis will have numerous implications for clinical practice. Prior to human testing, close consideration should be given to whether ectogenesis can be introduced as a continuation of existing neonatal care, with due attention to both safety risks to the fetus and pressures on pregnant persons to undergo experimental and/or invasive procedures. Equally important is the societal debate about the acceptable applications of ectogenesis and how access to these usages should be prioritized. It should be anticipated that clinical availability of ectogenesis, possibly first as a way to save extremely premature fetuses, may spark demand for non-medical purposes, like avoiding physical and social burdens of pregnancy.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1186/s12910-021-00630-6
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 71,355
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Why Abortion is Immoral.Don Marquis - 1989 - Journal of Philosophy 86 (4):183-202.

View all 66 references / Add more references

Citations of this work BETA

Regulating Abortion After Ectogestation.Joona Räsänen - forthcoming - Journal of Medical Ethics:medethics-2022-108174.

Add more citations

Similar books and articles

Medical Ethics and Broadening the Context of Debate.John McMillan - 2020 - Journal of Medical Ethics 46 (2):65-65.
Abortion and Ectogenesis: Moral Compromise.William Simkulet - 2020 - Journal of Medical Ethics 46 (2):93-98.
Artificial Wombs, Birth, and "Birth": A Response to Romanis.Nicholas Colgrove - 2019 - Journal of Medical Ethics:medethics-2019-105845.
Artificial Wombs, Birth and ‘Birth’: A Response to Romanis.Nick Colgrove - 2020 - Journal of Medical Ethics 46 (8):554-556.


Added to PP index

Total views
18 ( #611,110 of 2,519,607 )

Recent downloads (6 months)
7 ( #100,610 of 2,519,607 )

How can I increase my downloads?


My notes